title: [Chronic renal failure].
abstract: The elevated cardiovascular mortality seen in patients with renal insufficiency makes it imperative that this condition be detected and treated in good time. The results of recent studies have led to fundamental changes in the therapeutic approach to the patient with kidney disease. A range of new medications is now available for the treatment of complications of renal failure.
authors.affiliation: Nephrologisches Zentrum, Med. Poliklinik, Klinikum der Universität München - Innenstadt.
authors.forename: D
authors.initials: D
authors.lastname: Zecher
authors.forename: H J
authors.initials: HJ
authors.lastname: Anders
mesh_terms: D000141:Acidosis, Renal Tubular / Q000628:therapy; D000328:Adult; D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D008297:Male; D015201:Meta-Analysis as Topic; D011247:Pregnancy; D011379:Prognosis; D011507:Proteinuria / Q000175:diagnosis; D011788:Quality of Life; D011945:Receptors, Angiotensin / Q000187:drug effects; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D011945:Receptors, Angiotensin; D049993:Sodium Chloride Symporter Inhibitors; D003404:Creatinine